Compare OPTX & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OPTX | CTSO |
|---|---|---|
| Founded | 1981 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 273.5M | 23.9M |
| IPO Year | 2021 | 2008 |
| Metric | OPTX | CTSO |
|---|---|---|
| Price | $7.20 | $4.22 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $5.38 |
| AVG Volume (30 Days) | 249.2K | ★ 343.1K |
| Earning Date | 03-31-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 28.57 | ★ 65.79 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $22,503,908.00 |
| Revenue This Year | N/A | $10.34 |
| Revenue Next Year | N/A | $22.41 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 48.53 |
| 52 Week Low | $1.18 | $0.30 |
| 52 Week High | $14.92 | $7.44 |
| Indicator | OPTX | CTSO |
|---|---|---|
| Relative Strength Index (RSI) | 48.14 | 55.51 |
| Support Level | $7.06 | $0.47 |
| Resistance Level | $8.85 | $7.44 |
| Average True Range (ATR) | 0.48 | 0.58 |
| MACD | 0.07 | -0.26 |
| Stochastic Oscillator | 49.16 | 7.24 |
Syntec Optics Holdings Inc is vertically integrated from design and component manufacturing for lens system assembly to imaging module integration for system solutions. Making its tools, molding, and nano machining allows close interaction and recut ability, enabling special techniques to hold tolerances to sub-micron levels. It has steadily developed a variety of other complementary manufacturing techniques to provide a wide suite of horizontal capabilities including thin film deposition coatings, glass molding, polymer molding, tool-making, mechanical manufacturing, and nano machining. Syntec Optics focuses on four end markets of defense, medical, consumer, and communications all with several mission-critical applications.
CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.